期刊文献+

心后静脉X线解剖及其在心脏再同步化治疗中的应用 被引量:1

Angiographic anatomy of posterior ventricular vein and its application in cardiac resynchronization therapy
下载PDF
导出
摘要 目的:研究心后静脉的X线解剖特征,探索其在心脏再同步化治疗左室导线植入中的应用价值。方法:球囊逆行造影并通过交通支显影对78例患者的心后静脉直径及其与冠状静脉窦主干的角度进行观测,对成功植入左室导线的病例分析起搏参数。结果:所有患者均成功进行冠状静脉窦逆行造影,平均每位患者直径超过4F的分支血管有(1.63±0.49)个;40例(51.3%)患者可见心后静脉,22例(28.2%)患者成功植入左室起搏导线至心后静脉内。心后静脉直径(2.03±0.57)mm,其开口距离冠状静脉窦开口为(6.73±6.25)mm,与冠状静脉窦开口方向成角为(127.0±27.1)°;交通支显影方法有利于显示心后静脉,超选插管能显示心后静脉的分支,增加左室导线植入成功率。成功植入心后静脉的22例患者起搏阈值为(1.1±0.4)V。结论:心后静脉开口靠近冠状静脉窦口,交通支显影方法有利于显示心后静脉,心后静脉可作为左室电极导线植入路径。 Objective:To study the venographic characteristics of posterior ventricular vein(PVV) and explore its value in left ventricular lead implantation in cardiac resynchronization therapy(CRT).Methods:Retrograde cardiac venography with balloon through the communication branch was performed in 78 consecutive patients.Number of branches of cardiac coronary vein,the diameter of PVV,the distance of PVV to the coronary sinus ostium were measured.The pacing threshold of left ventricular lead implanted in PVV was recorded.Results:Retrograde coronary sinus venography was successfully done in all 78 patients.In average,these patients had 1.63 ± 0.49 vessel branches with diameter over 4French.PVV was seen in 40(51.3%) patients.Left ventricular leads were successfully implanted in 22(28.2%) patients in PVV.The average diameter of PVV was(2.03 ± 0.57) mm;the distance of PVV to the coronary sinus ostium was(6.73 ± 6.25) mm,with an angle of(127 ± 27.1)°.Communication branch imaging method was conducive to show PVV,ultra-elective insertion of the sheath into the PVV increased the success rate of left ventricular lead implantation.Pacing threshold of left ventricular lead in the 22 patients was(1.1 ± 0.4)V.Conclusion:The PVV joins the coronary venous near the coronary sinus ostium;communication branch imaging methods is conducive to show PVV.PVV is suitable for left ventricular lead implantation in cardiac resynchronization therapy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第12期1789-1791,共3页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省高校自然科学基金(09KJB320008)
关键词 心后静脉 再同步化治疗 起搏 posterior ventricular vein cardiac resynchronization therapy pacing
  • 相关文献

参考文献6

  • 1Dickstein K,Vardas PE,Auricchio A,et al. 2010 focused update of ESC guidelines on device therapy in heart fail- ure. An update of the 2008 ESC Guidelines for the diag- nosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy[J]. Eur Heart J,2010,3 l (21) :2677-2687.
  • 2Singh JP,Klein HU,Huang DT,et al. Left Ventricular Lead Position and Clinical Outcome in the Muhicenter Automatic Defibrillator Implantation Trial : Cardiac Resynchronization Therapy (MADIT-CRT) Trial[J]. Cir- culation , 2011,123( 11 ) : 1159-1166.
  • 3Khan FZ , Virdee M S, Gopalan D,et al. Characterization of the suitability of coronary venous anatomy for targeting left ventricular lead placement in patients undergoing car- diac resynehronization therapy [J]. Europace,2009, 11 (11) : 1491-1495.
  • 4楚建民,张澍,马坚,张奎俊,姚焰,王方正,陈新.心脏静脉逆行造影及其X线解剖学研究[J].中华心律失常学杂志,2000,4(4):247-249. 被引量:6
  • 5Crossley GH ,Exner D,Mead RH,et al. Chronic perfor- mance of an active fixation coronary sinus lead [J]. Heart Rhythm, 2010,7 (4) : 472-478.
  • 6侯小锋,邹建刚,单其俊,张文娟,徐东杰,李文奇,曹克将.慢性心力衰竭心脏再同步治疗超级反应患者的临床特征[J].中华心律失常学杂志,2011,15(2):94-98. 被引量:5

二级参考文献11

  • 1Rickard J, Kumbhani DJ, Popovic Z, et al. Characterization of super-response to eardiae resynchronization therapy. Heart Rhythm,2010,7 : 885-889.
  • 2Cappola TP, Harsch MR, Jessup M, et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. J Card Fail ,2006,12 : 182-188.
  • 3van Bommel RJ, Bax JJ, Abraham WT, et al. Characteristics of heart failure patients associated with good and poor response to car- diac resynchronization therapy: a PROSPECT ( Predictors of Re- sponse to CRT) sub-analysis. Eur Heart J,2009,30:2470-2477.
  • 4Moss A J, Hall W J, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med, 2009,361 : 1329-1338.
  • 5Dickstein K, Vardas PE, Auricchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynehronization therapy. Developed with the special contri- bution of the Heart Failure Association and the European Heart Rhythm Association. Europace ,2010,12 : 1526-1536.
  • 6Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med,20(M ,350:2140-2150.
  • 7Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med,2005,352 : 1539-1549.
  • 8Young JB, Abraham WT, Smith AL, et al. Combined cardiac resyn- chronization and implantable cardioversion defibrillation in ad- vanced chronic heart failure: the MIRACLE ICD TriM. JAMA, 2003,289:2685-2694.
  • 9Reant P, Zaroui A, Donal E, et al. Identification and characteriza- tion of super-responders after cardiac resynchronization therapy. Am J Cardiol,2010,105 : 1327-1335.
  • 10Antonio N,Teixeira R, C oelho L,et al, Identi? cation of ' super-re- sponders' to cardiac resynchronization therapy: the importanee of symptom duration and left ventricular geometry. Europace 2009, 11,343 -349.

共引文献9

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部